Bausch Health Co. Inc. (NYSE: BHC) reported GAAP Q3 EPS of $0.52, which does not compare to the analyst estimate of $1.04. Revenue for the quarter came in at $2.11 billion versus the consensus estimate of $2.15 billion.

GUIDANCE:

Bausch Health Co. Inc. reiterated FY2021 revenue of $8.4-8.6 billion and full-year Adjusted EBITDA (non-GAAP) range of $3.35 – $3.50 billion.

For earnings history and earnings-related data on Bausch Health Co. Inc. (BHC) click here.